Markéta Kolaříková
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Markéta Kolaříková has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Hanna Dilenko
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University, Hněvotinska 3, Olomouc 77900, Czech Republic
6 shared publications - Katerina Tomankova
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hněvotínská 976/3, 779 00 Olomouc, Czech Republic
5 shared publications - Hana Kolarova
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hnevotinska 3, 775 15 Olomouc, Czech Republic
4 shared publications - Lukáš Malina
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc
4 shared publications - Kateřina Langová
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hněvotínská 976/3, 779 00 Olomouc, Czech Republic
3 shared publications - Milan Kolář
Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515 Olomouc, Czech Republic
3 shared publications
Latest Publications
- Open Access
- 19 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4550
Investigating the Efficacy of Various Photosensitizers and Irradiation Strategies in Antimicrobial Photodynamic Inactivation on Different Types of Microbes
Antimicrobial photodynamic therapy is a method that utilizes photodynamic inactivation of microorganisms exposed to a photosensitizer irradiated by a specific wavelength, followed by the formation of reactive oxygen species and subsequent oxidative stress. In contrast to antibiotics, which are generally efficient against specific microorganisms, photodynamic inactivation exhibits efficacy against a wide range of bacteria, representing a promising and non-invasive alternative to treating infections caused by pathogens of different origins. This study compares the antibacterial efficacy of five different photosensitizers, including TMPyP, Protoporphyrin IX, PdTPPS4, Methylene Blue, and ZnPCS2, against eight representatives of various pathogens, including Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa, Gram-positive bacteria Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus faecium, MRSA and Bacillus subtilis. An optimal irradiation protocol was developed based on growth curve measurements involving double irradiation. To induce the photodynamic effect, we utilized LED emitters with wavelengths of 414 nm and 660 nm, chosen to align with the photophysical properties of the photosensitizers. Additionally, the research included assessments of the radiation’s phototoxicity and the photosensitizers’ dark toxicity against specific microorganisms. The optical properties of the photosensitizers were analyzed using absorption spectrophotometry. The effectiveness of photodynamic inactivation was assessed by determining the minimum inhibitory and bactericidal concentrations. This study aimed to identify the most suitable photosensitizer for clinical application, considering the toxicity of the photosensitizer, the radiant exposure, and its efficacy in photodynamic inactivation.
- 19 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4550
Open AccessInvestigating the Efficacy of Various Photosensitizers and Irradiation Strategies in Antimicrobial Photodynamic Inactivation on Different Types of Microbes
Antimicrobial photodynamic therapy is a method that utilizes photodynamic inactivation of microorganisms exposed to a photosensitizer irradiated by a specific wavelength, followed by the formation of reactive oxygen species and subsequent oxidative stress. In contrast to antibiotics, which are generally efficient against specific microorganisms, photodynamic inactivation exhibits efficacy against a wide range of bacteria, representing a promising and non-invasive alternative to treating infections caused by pathogens of different origins. This study compares the antibacterial efficacy of five different photosensitizers, including TMPyP, Protoporphyrin IX, PdTPPS4, Methylene Blue, and ZnPCS2, against eight representatives of various pathogens, including Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa, Gram-positive bacteria Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus faecium, MRSA and Bacillus subtilis. An optimal irradiation protocol was developed based on growth curve measurements involving double irradiation. To induce the photodynamic effect, we utilized LED emitters with wavelengths of 414 nm and 660 nm, chosen to align with the photophysical properties of the photosensitizers. Additionally, the research included assessments of the radiation’s phototoxicity and the photosensitizers’ dark toxicity against specific microorganisms. The optical properties of the photosensitizers were analyzed using absorption spectrophotometry. The effectiveness of photodynamic inactivation was assessed by determining the minimum inhibitory and bactericidal concentrations. This study aimed to identify the most suitable photosensitizer for clinical application, considering the toxicity of the photosensitizer, the radiant exposure, and its efficacy in photodynamic inactivation.
- Open Access
- 13 March 2026
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 278, 113426
Effectiveness of photodynamic therapy against Escherichia coli: Influence of light dose fractionation in the presence of porphyrins, methylene blue and zinc phthalocyanine disulfonate
- 13 March 2026
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 278, 113426
Open AccessEffectiveness of photodynamic therapy against Escherichia coli: Influence of light dose fractionation in the presence of porphyrins, methylene blue and zinc phthalocyanine disulfonate
- Open Access
- 22 November 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 193, 118783
Hyaluronic acid-functionalized liposomes for CD44-targeted anticancer therapy: In Vitro induced cytotoxicity in HeLa cells
- 22 November 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 193, 118783
Open AccessHyaluronic acid-functionalized liposomes for CD44-targeted anticancer therapy: In Vitro induced cytotoxicity in HeLa cells
- Open Access
- 5 November 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 193, 118696
Carboxylated graphene quantum dots as a nano-delivery system for insoluble curcumin in antimicrobial photodynamic therapy
- 5 November 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 193, 118696
Open AccessCarboxylated graphene quantum dots as a nano-delivery system for insoluble curcumin in antimicrobial photodynamic therapy
- Open Access
- 28 April 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 187, 118096
Illuminating the dark: PEGylated carboxylated graphene quantum dots and curcumin in nucleolar activity and PDT-induced DNA damage in cancer
- 28 April 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 187, 118096
Open AccessIlluminating the dark: PEGylated carboxylated graphene quantum dots and curcumin in nucleolar activity and PDT-induced DNA damage in cancer
- Open Access
- 3 October 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (19) , 10650
Effects of Zinc Phthalocyanine Photodynamic Therapy on Vital Structures and Processes in Hela Cells
This work presents results on the efficiency of newly designed zinc phthalocyanine-mediated photodynamic therapy of both tumoral and nontumoral cell models using the MTT assay. Further detailed examinations of mechanistic and cell biological effects were focused on the HELA cervical cancer cell model. Here, ROS production, changes in the mitochondrial membrane potential, the determination of genotoxicity, and protein changes determined by capillary chromatography and tandem mass spectrometry with ESI were analyzed. The results showed that, in vitro, 5 Jcm−2 ZnPc PDT caused a significant increase in reactive oxygen species. Still, except for superoxide dismutase, the levels of proteins involved in cell response to oxidative stress did not increase significantly. Furthermore, this therapy damaged mitochondrial membranes, which was proven by a more than 70% voltage-dependent channel protein 1 level decrease and by a 65% mitochondrial membrane potential change 24 h post-therapy. DNA impairment was assessed by an increased level of DNA fragmentation, which might be related to the decreased level of DDB1 (decrease in levels of more than 20% 24 h post-therapy), a protein responsible for maintaining genomic integrity and triggering the DNA repair pathways. Considering these results and the low effective concentration (LC50 = 30 nM), the therapy used is a potentially very promising antitumoral treatment.
- 3 October 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (19) , 10650
Open AccessEffects of Zinc Phthalocyanine Photodynamic Therapy on Vital Structures and Processes in Hela Cells
This work presents results on the efficiency of newly designed zinc phthalocyanine-mediated photodynamic therapy of both tumoral and nontumoral cell models using the MTT assay. Further detailed examinations of mechanistic and cell biological effects were focused on the HELA cervical cancer cell model. Here, ROS production, changes in the mitochondrial membrane potential, the determination of genotoxicity, and protein changes determined by capillary chromatography and tandem mass spectrometry with ESI were analyzed. The results showed that, in vitro, 5 Jcm−2 ZnPc PDT caused a significant increase in reactive oxygen species. Still, except for superoxide dismutase, the levels of proteins involved in cell response to oxidative stress did not increase significantly. Furthermore, this therapy damaged mitochondrial membranes, which was proven by a more than 70% voltage-dependent channel protein 1 level decrease and by a 65% mitochondrial membrane potential change 24 h post-therapy. DNA impairment was assessed by an increased level of DNA fragmentation, which might be related to the decreased level of DDB1 (decrease in levels of more than 20% 24 h post-therapy), a protein responsible for maintaining genomic integrity and triggering the DNA repair pathways. Considering these results and the low effective concentration (LC50 = 30 nM), the therapy used is a potentially very promising antitumoral treatment.
- Open Access
- 1 June 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 5637-5680
Graphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review
Photodynamic therapy (PDT) is a non-invasive therapy that has made significant progress in treating different diseases, including cancer, by utilizing new nanotechnology products such as graphene and its derivatives. Graphene-based materials have large surface area and photothermal effects thereby making them suitable candidates for PDT or photo-active drug carriers. The remarkable photophysical properties of graphene derivates facilitate the efficient generation of reactive oxygen species (ROS) upon light irradiation, which destroys cancer cells. Surface functionalization of graphene and its materials can also enhance their biocompatibility and anticancer activity. The paper delves into the distinct roles played by graphene-based materials in PDT such as photosensitizers (PS) and drug carriers while at the same time considers how these materials could be used to circumvent cancer resistance. This will provide readers with an extensive discussion of various pathways contributing to PDT inefficiency. Consequently, this comprehensive review underscores the vital roles that graphene and its derivatives may play in emerging PDT strategies for cancer treatment and other medical purposes. With a better comprehension of the current state of research and the existing challenges, the integration of graphene-based materials in PDT holds great promise for developing targeted, effective, and personalized cancer treatments.
- 1 June 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 5637-5680
Open AccessGraphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review
Photodynamic therapy (PDT) is a non-invasive therapy that has made significant progress in treating different diseases, including cancer, by utilizing new nanotechnology products such as graphene and its derivatives. Graphene-based materials have large surface area and photothermal effects thereby making them suitable candidates for PDT or photo-active drug carriers. The remarkable photophysical properties of graphene derivates facilitate the efficient generation of reactive oxygen species (ROS) upon light irradiation, which destroys cancer cells. Surface functionalization of graphene and its materials can also enhance their biocompatibility and anticancer activity. The paper delves into the distinct roles played by graphene-based materials in PDT such as photosensitizers (PS) and drug carriers while at the same time considers how these materials could be used to circumvent cancer resistance. This will provide readers with an extensive discussion of various pathways contributing to PDT inefficiency. Consequently, this comprehensive review underscores the vital roles that graphene and its derivatives may play in emerging PDT strategies for cancer treatment and other medical purposes. With a better comprehension of the current state of research and the existing challenges, the integration of graphene-based materials in PDT holds great promise for developing targeted, effective, and personalized cancer treatments.